Stryker Corporation (BVMF:S1YK34)
| Market Cap | 681.75B -22.2% |
| Revenue (ttm) | 138.34B +11.2% |
| Net Income | 17.88B +8.5% |
| EPS | 46.27 +8.2% |
| Shares Out | n/a |
| PE Ratio | 38.13 |
| Forward PE | 22.24 |
| Dividend | 0.63 (0.70%) |
| Ex-Dividend Date | Dec 30, 2025 |
| Volume | 11,043 |
| Average Volume | 1,511 |
| Open | 89.37 |
| Previous Close | n/a |
| Day's Range | 89.37 - 89.37 |
| 52-Week Range | 87.75 - 112.50 |
| Beta | 0.87 |
| RSI | 36.26 |
| Earnings Date | Apr 30, 2026 |
About Stryker
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally inv... [Read more]
Financial Performance
In 2025, Stryker's revenue was $25.12 billion, an increase of 11.16% compared to the previous year's $22.60 billion. Earnings were $3.25 billion, an increase of 8.45%.
Financial numbers in USD Financial StatementsNews
US agency asks companies to secure Microsoft tool after Stryker cyberattack
The U.S. government on Wednesday asked companies to strengthen the security of Microsoft's endpoint management tool, after a cyberattack on medical device maker Stryker Corp last week.
Stryker cyberattack delays surgeries for some patients, Bloomberg News reports
A cyberattack against medical device maker Stryker last week has delayed surgeries for some patients, Bloomberg News reported on Wednesday.
GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE: SYK), to its Board of Directors...
Stryker says cyberattack on its network contained
Medical device maker Stryker said on Tuesday it has contained a cyberattack that caused widespread disruption to its business and was now prioritizing restoring systems that directly support custome...
Invesco Rising Dividends Fund Q4 2025 Portfolio Activity
Linde was purchased due to its essential and resilient business model, anchored by long-term contracts and leadership in industrial gases. We sold Oracle due to concerns about downside risk as its inv...
Stock Of The Day: Where Is The Bottom For Stryker?
Despite the unusual and surprising news, the stock still followed a predictable pattern. This is why Stryker is the Stock of the Day.
Stryker flags disruption to orders, manufacturing a day after cyberattack
Medical device maker Stryker said on Thursday a cyberattack that hit its computer systems a day earlier is causing widespread disruption to its business, including its ability to process orders, mak...
Stryker Says Cyberattack Disruption Is Continuing
The company experienced a global disruption to its Microsoft systems following a cyberattack related to the Iranian conflict.
Stryker shares fall after report on suspected Iran-linked cyberattack
Stryker's shares fell about 3% on Wednesday after the Wall Street Journal reported that the medical equipment maker was hit by a suspected Iran-linked cyberattack.
Stryker launches SmartHospital Platform
New platform connects devices, data and care teams across the patient journey to streamline operations and enhance outcomes for patients and staff PORTAGE, Mich., March 9, 2026 /PRNewswire/ -- Stryker...
Baron Health Care Fund Q4 2025 Recent Activity
During the quarter, Baron Health Care Fund added seven new positions and exited ten positions, bringing the number of positions in the Fund to 43. We bought shares of Arcutis Biotherapeutics, Inc., a ...
Baron Health Care Fund Q4 2025 Contributors And Detractors
Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gain strong traction. Cidara Therapeutics' shares rose further following Merck's acquisition of the com...
Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting
Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technol...
Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
Elevating care with Stryker's next generation device, Synchfix EVT, which will be featured at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting PORTAGE, Mich., Feb. 24, 2026 ...
Stryker launches T2 Alpha Humerus Nailing System, supporting surgical workflow and care for complex fractures
PORTAGE, Mich., Feb. 11, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of the T2 Alpha Humerus Nailing System, the latest addition to its T2 A...
Stryker introduces Mako Handheld Robotics with the limited market release of Mako RPS
PORTAGE, Mich., Feb. 9, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the limited market release of Mako RPS (Robotic Power System) for Total Knee, an in...
Stryker declares an $0.88 per share quarterly dividend
Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholde...
Stryker Corporation (SYK) Q4 2025 Earnings Call Transcript
Stryker Corporation (SYK) Q4 2025 Earnings Call Transcript
Stryker raises annual profit forecast on strong sales for medical devices
Medical equipment maker Stryker raised its full-year profit forecast on Thursday, banking on strong sales of its implants and other medical devices.
Stryker reports 2025 operating results and 2026 outlook
Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025:
Despite Reassurances On Growth, The Market Hasn't Warmed To Stryker
Stryker offers above-average revenue growth, robust margin leverage, and a compelling valuation relative to med-tech peers despite sector-wide derating risks. Key growth drivers include Mako's continu...
VB Spine Completes Acquisition of Cestas Manufacturing Facility from Stryker
NEW YORK--(BUSINESS WIRE)--VB Spine completes the acquisition of Stryker's Cestas, France spinal implant manufacturing facility.
Stryker to announce financial results for its fourth quarter and full year 2025
Portage, Michigan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its fourth quarter and full year 2025 on Thursday, January 29, 2026. A pres...
Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January
Chevron (CVX) is expected to extend its dividend growth streak to 39 years, but with a muted 3–4% increase amid lower oil prices. CVX's earnings remain under pressure from declining oil prices despite...
Stryker names Spencer Stiles President and Chief Operating Officer
Portage, Michighan, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today Spencer Stiles has been appointed President and Chief Operating Offic...